DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Leucovorin (Leucovorin) - Reports of Side Effects & Adverse Reactions

 


Nutrilib.com
A comprihensive source of nutritional information

This is an index of adverse event reports related to Leucovorin. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (37)
     Abdominal Pain (6)Vomiting (5)Diarrhoea (4)more >>

Cases resulting in a serious event (37)
     Abdominal Pain (6)Vomiting (5)Diarrhoea (4)more >>

Cases resulting in death (11)
     Anal Fistula (2)Lower Gastrointestinal Haemorrhage (2)Rectal Abscess (2)more >>

Cases resulting in life threatening events (5)
     Agitation (1)White Blood Cell Count Decreased (1)Anaemia (1)more >>

Cases resulting in hospitalization (23)
     Abdominal Pain (5)Vomiting (4)Diarrhoea (4)more >>

Cases resulting in other serious reactions (8)
     Nausea (1)Pancytopenia (1)Pulmonary Embolism (1)more >>

Below is a sample of adverse event reports reports related to Leucovorin. For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in female receiving Leucovorin

Reported by a consumer/non-health professional from United Kingdom on 2007-10-31

Patient: female, weighing 61.5 kg (135.3 pounds)

Adverse reactions / side effects: Vomiting, Diarrhoea, Hypokalaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 326 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Fluorouracil
    Dosage: 650 mg, q2w
    Start date: 2007-04-04

Leucovorin
    Dosage: 320 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Oxaliplatin
    Dosage: 137 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Other drugs received by patient: Rabeprazole Sodium; Zofran; Prochlorperazine; Aluminum Hydroxide Gel; Norvasc; Bisoprolol Fumarate; Ramipril



Adverse event in 77 year old male receiving Leucovorin

Reported by a physician from Germany on 2007-10-31

Patient: 77 year old male

Adverse reactions / side effects: Nephrotic Syndrome, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Erbitux
    Indication: Colon Cancer
    Start date: 2006-08-10
    End date: 2007-02-13

Fluorouracil
    Dosage: no.of dosage=d1+d2
    Indication: Colon Cancer
    Start date: 2005-07-19
    End date: 2007-02-13

Irinotecan HCL
    Indication: Colon Cancer
    Start date: 2005-07-19
    End date: 2007-02-13

Leucovorin
    Dosage: no.of dosage=d1+d2
    Indication: Colon Cancer
    Start date: 2005-07-19
    End date: 2007-02-13

Other drugs received by patient: Penmix



Adverse event in female receiving Leucovorin

Reported by a physician from Egypt on 2007-10-30

Patient: female, weighing 65.0 kg (143.0 pounds)

Adverse reactions / side effects: Pneumonia, Pancytopenia

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Fluorouracil
    Dosage: 400 mg/m2 bolus followed by 600 mg/m2 infusion
    Start date: 2006-12-18
    End date: 2006-12-19

Leucovorin
    Start date: 2006-12-18
    End date: 2006-12-19

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2006-12-18
    End date: 2006-12-18



Adverse event in male receiving Leucovorin

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29

Patient: male, weighing 175.0 kg (385.0 pounds)

Adverse reactions / side effects: Hepatic Failure, Disease Progression

Adverse event resulted in: hospitalization

Suspect drug(s):
Aranesp
    Dosage: 200 a?g, prn
    Indication: Anaemia

Avastin
    Dosage: 590 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-08-02

Fluorouracil
    Dosage: 1140 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-07-20

Fluorouracil
    Dosage: 760 mg, unk
    Start date: 2005-08-02
    End date: 2005-08-03

Fluorouracil
    Dosage: 1140 mg, unk
    Start date: 2005-08-02
    End date: 2005-08-04

Leucovorin
    Dosage: 380 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-08-03

Oxaliplatin
    Dosage: 160 mg, unk
    Indication: Metastatic Neoplasm
    Start date: 2005-07-18
    End date: 2005-08-02



Adverse event in female receiving Leucovorin

Reported by a physician from United Kingdom on 2007-10-25

Patient: female, weighing 137.8 kg (303.2 pounds)

Adverse reactions / side effects: Abdominal Pain, Vomiting, Pyrexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 312.5 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Fluorouracil
    Dosage: 660 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Leucovorin
    Dosage: 660 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Oxaliplatin
    Dosage: 140 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-23

Other drugs received by patient: Neupogen; Modulon; Iron Supplement



Adverse event in 65 year old female receiving Leucovorin

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-25

Patient: 65 year old female

Adverse reactions / side effects: Sudden Death

Adverse event resulted in: death

Suspect drug(s):
Eloxatin
    Dosage: unk
    Indication: Colon Cancer Metastatic
    Start date: 2007-10-10
    End date: 2007-10-10

Fluorouracil
    Dosage: unk
    Indication: Colon Cancer Metastatic

Leucovorin
    Dosage: unk
    Indication: Colon Cancer Metastatic
    Start date: 2007-10-10
    End date: 2007-10-10

Other drugs received by patient: Anzemet; Decadron



Adverse event in female receiving Leucovorin

Reported by a physician from United States on 2007-10-24

Patient: female

Adverse reactions / side effects: Asthenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Fluorouracil

Irinotecan HCL

Leucovorin

Panitumumab
    Indication: Colorectal Cancer
    Start date: 2007-07-26

Panitumumab
    Start date: 2007-08-14
    End date: 2007-08-14

Other drugs received by patient: Synthroid; Wellbutrin



Adverse event in male receiving Leucovorin

Reported by a individual with unspecified qualification from United States on 2007-10-24

Patient: male, weighing 27.9 kg (61.4 pounds)

Adverse reactions / side effects: Cholecystitis Acute, Enterobacter Sepsis

Adverse event resulted in: hospitalization

Suspect drug(s):
Fluorouracil
    Indication: Metastatic Neoplasm
    Start date: 2007-08-07
    End date: 2007-08-19

Fluorouracil

Irinotecan HCL
    Indication: Metastatic Neoplasm

Leucovorin
    Indication: Metastatic Neoplasm

Sutent
    Dosage: daily dose:25mg-freq:1 daily
    Administration route: Oral
    Indication: Metastatic Neoplasm
    Start date: 2007-08-08
    End date: 2007-08-20



Adverse event in female receiving Leucovorin

Reported by a physician from Italy on 2007-10-23

Patient: female

Adverse reactions / side effects: White Blood Cell Count Decreased, Fatigue, Anaemia, Lymphocytic Leukaemia, Pyrexia, Hyperhidrosis, Cerebral Haemorrhage

Adverse event resulted in: death, life threatening event

Suspect drug(s):
Eloxatin
    Indication: Colon Cancer
    Start date: 2005-11-01
    End date: 2006-05-01

Eloxatin
    Indication: Sigmoidectomy
    Start date: 2005-11-01
    End date: 2006-05-01

Fluorouracil
    Dosage: unk
    Indication: Colon Cancer
    Start date: 2005-11-01
    End date: 2006-05-01

Leucovorin
    Dosage: unk
    Indication: Colon Cancer
    Start date: 2005-11-01
    End date: 2006-05-01



Adverse event in male receiving Leucovorin

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23

Patient: male, weighing 175.0 kg (385.0 pounds)

Adverse reactions / side effects: Abdominal Pain, Jaundice, Metastatic Neoplasm, Bile Duct Obstruction, Malignant Neoplasm Progression, Hepatic Failure, Oedema Peripheral, Abdominal Distension, Decreased Appetite, Lethargy

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Aranesp
    Indication: Anaemia

Avastin
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-02

Avastin
    Dosage: unk

Fluorouracil
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-04

Leucovorin
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-03

Oxaliplatin
    Indication: Metastatic Neoplasm
    Start date: 2005-08-02
    End date: 2005-08-02



Adverse event in female receiving Leucovorin

Reported by a physician from United States on 2007-10-23

Patient: female

Adverse reactions / side effects: Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Fluorouracil

Irinotecan HCL

Leucovorin

Panitumumab
    Indication: Colorectal Cancer
    Start date: 2007-09-13



Adverse event in male receiving Leucovorin

Reported by a physician from United States on 2007-10-23

Patient: male

Adverse reactions / side effects: Dehydration, Sepsis, Paraneoplastic Syndrome

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Bevacizumab
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-09
    End date: 2007-07-09

Eloxatin
    Dosage: 65 mg/m2 (131.3 mg) every 2 weeks
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-09
    End date: 2007-07-09

Fluorouracil
    Dosage: 606 mg bolus (300 mg/m2); 3636 mg (1800 mg/m2) every 2 weeks
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-11
    End date: 2007-07-11

Leucovorin
    Dosage: 800 mg (400 mg/m2) every 2 weeks
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-07-09
    End date: 2007-07-09

Other drugs received by patient: Multi-Vitamin; Lipitor; Digitek; Pepcid; Cardizem; Cozaar; Coumadin; Megace; Nystatin



Adverse event in female receiving Leucovorin

Reported by a physician from United States on 2007-10-22

Patient: female, weighing 66.8 kg (147.0 pounds)

Adverse reactions / side effects: Transient Ischaemic Attack

Suspect drug(s):
Bevacizumab
    Start date: 2006-05-15
    End date: 2006-05-15

CA / MG OR Placebo
    Start date: 2006-05-15
    End date: 2006-05-15

Fluorouracil
    Dosage: 2400 mg/m2 iv on day 1 and day 2, q2w
    Start date: 2006-05-15
    End date: 2006-05-16

Leucovorin
    Start date: 2006-05-15
    End date: 2006-05-15

Oxaliplatin
    Indication: Colorectal Cancer Metastatic
    Start date: 2006-05-15
    End date: 2006-05-15



Adverse event in female receiving Leucovorin

Reported by a consumer/non-health professional from United Kingdom on 2007-10-19

Patient: female, weighing 61.5 kg (135.3 pounds)

Adverse reactions / side effects: Vomiting, Blood Potassium Decreased, Diarrhoea

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 326 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Fluorouracil
    Dosage: 650 mg, q2w
    Start date: 2007-04-04

Leucovorin
    Dosage: 320 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Oxaliplatin
    Dosage: 137 mg, q2w
    Indication: Colon Cancer
    Start date: 2007-04-04

Other drugs received by patient: Rabeprazole Sodium; Zofran; Prochlorperazine; Aluminum Hydroxide Gel; Norvasc; Bisoprolol Fumarate; Ramipril



Adverse event in 74 year old male receiving Leucovorin

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19

Patient: 74 year old male

Adverse reactions / side effects: Myelodysplastic Syndrome, Rash Pruritic

Suspect drug(s):
Epirubicin
    Indication: Oesophageal Adenocarcinoma

Etoposide
    Indication: Oesophageal Adenocarcinoma

Fluorouracil
    Indication: Oesophageal Adenocarcinoma

Leucovorin
    Indication: Oesophageal Adenocarcinoma

Methotrexate
    Indication: Oesophageal Adenocarcinoma

Mitomycin
    Indication: Oesophageal Adenocarcinoma

Proleukin
    Indication: Oesophageal Adenocarcinoma

Radiotherapy
    Indication: Oesophageal Adenocarcinoma



Adverse event in female receiving Leucovorin

Reported by a physician from United States on 2007-10-19

Patient: female, weighing 130.2 kg (286.4 pounds)

Adverse reactions / side effects: Abdominal Pain, Vomiting, Nausea, Heart Rate Increased, Pancytopenia, Neutropenia, Pyrexia, Blood Pressure Decreased

Suspect drug(s):
Eloxatin
    Indication: Colon Cancer Stage III
    Start date: 2007-01-01
    End date: 2007-01-01

Fluorouracil
    Indication: Colon Cancer Stage III
    Start date: 2006-07-30
    End date: 2006-07-30

Leucovorin
    Indication: Colon Cancer Stage III
    Start date: 2006-07-30
    End date: 2006-07-30

Other drugs received by patient: Aranesp; Neupogen; Restoril; Ambien; Lunesta; Lantus; Avandia; Zestril; Glucotrol; Glucophage; Zocor; Dexamethasone 0.5mg TAB; Zofran



Adverse event in female receiving Leucovorin

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19

Patient: female, weighing 57.6 kg (126.7 pounds)

Adverse reactions / side effects: Abdominal Pain, Empty Sella Syndrome, Diarrhoea, Septic Shock, Cerebrovascular Accident

Adverse event resulted in: hospitalization

Suspect drug(s):
Fluorouracil
    Indication: Colorectal Cancer

Leucovorin
    Indication: Colorectal Cancer

Oxaliplatin
    Indication: Colorectal Cancer
    Start date: 2007-07-25
    End date: 2007-07-25

Other drugs received by patient: Lipitor; Hydrochlorothiazide; Xanax



Adverse event in female receiving Leucovorin

Reported by a physician from United Kingdom on 2007-10-16

Patient: female

Adverse reactions / side effects: Renal Failure, Reversible Posterior Leukoencephalopathy Syndrome, Headache, Hypertension

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 5 mg/kg, q2w
    Indication: Rectal Cancer
    Start date: 2007-06-25

Eloxatin
    Dosage: 85 mg/m2, q2w
    Indication: Rectal Cancer
    Start date: 2007-06-25

Fluorouracil
    Dosage: 400 mg/m2, q2w/x3
    Indication: Rectal Cancer
    Start date: 2007-06-25

Lasix
    Dosage: 20 mg, qd
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Leucovorin
    Dosage: 400 mg/m2, q2w
    Indication: Rectal Cancer
    Start date: 2007-06-25

Lisinopril
    Dosage: 7.5 mg, qd
    Indication: Drug USE FOR Unknown Indication



Adverse event in male receiving Leucovorin

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-15

Patient: male, weighing 77.1 kg (169.6 pounds)

Adverse reactions / side effects: Anal Fistula, Gastrointestinal Anastomotic Leak, Lower Gastrointestinal Haemorrhage, Rectal Abscess

Adverse event resulted in: death

Suspect drug(s):
Bevacizumab
    Start date: 2007-07-11
    End date: 2007-07-11

Fluorouracil
    Dosage: 400 mg/m2 iv bolus on d1 then 2.4 g/m2 as continuous infusion over 46 h
    Start date: 2007-07-12
    End date: 2007-07-13

Leucovorin
    Start date: 2007-07-11
    End date: 2007-07-11

Oxaliplatin
    Indication: Rectal Cancer
    Start date: 2007-07-11
    End date: 2007-07-11

Other drugs received by patient: Reglan; Zofran; Ativan; Procrit; Vicodin; Radiation



Adverse event in receiving Leucovorin

Reported by a consumer/non-health professional from United Kingdom on 2007-10-12

Patient:

Adverse reactions / side effects: Death

Adverse event resulted in: death

Suspect drug(s):
Avastin
    Dosage: 5 mg/kg, qow
    Indication: Colorectal Cancer Metastatic

Fluorouracil
    Dosage: 500 mg/m2, 1/week
    Indication: Colorectal Cancer Metastatic

Leucovorin
    Dosage: 500 mg/m2, q8w
    Indication: Colorectal Cancer Metastatic



Adverse event in male receiving Leucovorin

Reported by a physician from United Kingdom on 2007-10-11

Patient: male

Adverse reactions / side effects: Pulmonary Hypertension, Pulmonary Embolism, Tumour Embolism, Alveolitis Allergic, Disease Progression, Cardio-Respiratory Arrest, Cardiac Failure, Arterial Spasm, Shock

Suspect drug(s):
Bevacizumab
    Dosage: 100 unit, unk
    Indication: Colon Cancer
    Start date: 2007-09-03
    End date: 2007-09-08

Fluorouracil
    Indication: Colon Cancer
    Start date: 2007-09-03

Leucovorin
    Indication: Colon Cancer
    Start date: 2007-09-03

Oxaliplatin
    Indication: Colon Cancer
    Start date: 2007-09-03



Adverse event in female receiving Leucovorin

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-10

Patient: female, weighing 65.3 kg (143.7 pounds)

Adverse reactions / side effects: Gastric Cancer

Suspect drug(s):
Bevacizumab
    Dosage: 350 mg, q2w
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-02-23

Cetuximab
    Dosage: 470 mg, 1/week
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-02-23

Fluorouracil
    Dosage: 712 mg, q2w
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-02-23

Fluorouracil
    Dosage: 4072 mg, q2w

Leucovorin
    Dosage: 712 mg, q2w
    Indication: Colorectal Cancer Metastatic
    Start date: 2007-02-23

Other drugs received by patient: Coumadin; Benadryl; Tylenol (Caplet); Decadron



Adverse event in receiving Leucovorin

Reported by a physician from United States on 2007-10-10

Patient:

Adverse reactions / side effects: Diaphragmatic Paralysis

Suspect drug(s):
Eloxatin
    Dosage: unk
    Indication: Drug USE FOR Unknown Indication

Fluorouracil
    Dosage: unk
    Indication: Drug USE FOR Unknown Indication

Leucovorin
    Dosage: unk
    Indication: Drug USE FOR Unknown Indication



Adverse event in 53 year old male receiving Leucovorin

Reported by a physician from United States on 2007-10-09

Patient: 53 year old male

Adverse reactions / side effects: Myocardial Infarction

Adverse event resulted in: hospitalization

Suspect drug(s):
Avastin
    Indication: Rectal Cancer
    Start date: 2007-09-17
    End date: 2007-09-17

Eloxatin
    Indication: Rectal Cancer
    Start date: 2007-09-17
    End date: 2007-09-17

Fluorouracil
    Indication: Rectal Cancer
    Start date: 2007-09-17
    End date: 2007-09-17

Leucovorin
    Indication: Rectal Cancer
    Start date: 2007-09-17
    End date: 2007-09-17



Adverse event in male receiving Leucovorin

Reported by a consumer/non-health professional from United Kingdom on 2007-10-08

Patient: male, weighing 92.0 kg (202.4 pounds)

Adverse reactions / side effects: Oesophagitis, Gastritis

Adverse event resulted in: hospitalization

Suspect drug(s):
Bevacizumab
    Dosage: 460 mg, q2w
    Indication: Colon Cancer
    Start date: 2005-12-13
    End date: 2006-03-21

Fluorouracil
    Dosage: 840 mg, 2/week/q2w
    Indication: Colon Cancer
    Start date: 2005-12-13

Fluorouracil
    Dosage: 1260 mg, 2/week/q2w
    Start date: 2005-12-13

Leucovorin
    Dosage: 420 mg, q2w
    Indication: Colon Cancer
    Start date: 2005-12-13

Oxaliplatin
    Dosage: 178 mg, q2w
    Indication: Colon Cancer
    Start date: 2005-12-13

Other drugs received by patient: Epoetin Beta

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008